ZZU School of Pharmacy Makes Progress in Anti-tumor Nano immunochemotherapy

24 June,2020
Share to

Recently, the School of Pharmacy, ZZU has made positive progress in the field of nano-immunochemotherapy to enhance anti-tumor natural immunity. The top journal ACS Nano (IF = 13.903). Prof. Hou Lin and Prof. Zhang Zhenzhong of the School of Pharmacy are the corresponding authors, and ZZU is the sole corresponding author unit.